Get started
Zelira Therapeutics Ltd.Zelira Therapeutics Ltd.Zelira Therapeutics Ltd.

Zelira Therapeutics Ltd.

No trades
No trades
OverviewFinancialsNewsCommunityTechnicalsSeasonals
Full chart
Full chart

Compare with Zelira Therapeutics Ltd.



Key stats


Market capitalization
‪5.95 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−3.63 M‬ AUD
Revenue (FY)
656.00 AUD
Shares float
‪12.56 M‬
Beta (1Y)
5.28

Details


Sector
Health Technology
Industry
Pharmaceuticals: Other
CEO
Oludare Odumosu
Website
zeliratx.com
Headquarters
Perth
Founded
2003
IPO date
Jul 28, 2003
ISIN
AU000000ZLD1
FIGI
BBG000K4GYF0
Identifiers
ISIN AU000000ZLD1
CFI code
ESVUFR
Zelira Therapeutics Ltd. is a bio-pharmaceutical company, which engages in the research, development and commercialisation of cannabinoid-based formulations for the treatment of a variety of medical conditions. It operates through the following geographical segments: Australia and USA. The company was founded by Harry Karelis, Mara Gordon, Jason Peterson, and Stewart Washer on February 18, 2003 and is headquartered in Perth, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of ZLD is 0.500 AUD — it hasn't changed in the past 24 hours. Watch Zelira Therapeutics Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange Zelira Therapeutics Ltd. stocks are traded under the ticker ZLD.
ZLD reached its all-time high on May 5, 2008 with the price of 391.015 AUD, and its all-time low was 0.275 AUD and was reached on Jun 28, 2024. View more price dynamics on ZLD chart.
See other stocks reaching their highest and lowest prices.
ZLD stock is 3.09% volatile and has beta coefficient of 5.28. Track Zelira Therapeutics Ltd. stock price on the chart and check out the list of the most volatile stocks — is Zelira Therapeutics Ltd. there?
Today Zelira Therapeutics Ltd. has the market capitalization of ‪6.57 M‬, it has decreased by −3.85% over the last week.
Yes, you can track Zelira Therapeutics Ltd. financials in yearly and quarterly reports right on TradingView.
No, ZLD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ZLD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Zelira Therapeutics Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Zelira Therapeutics Ltd. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Zelira Therapeutics Ltd. stock shows the sell signal. See more of Zelira Therapeutics Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.